Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic

BACKGROUND: Surgical delays are associated with invasive cancer for patients with ductal carcinoma in situ (DCIS). During the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic, neoadjuvant endocrine therapy (NET) was used as a bridge until postponed surgeries resumed. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Austin D., Chang, Cecilia, Sigurdson, Elin R., Wang, Chih-Hsiung, Aggon, Allison A., Hill, Maureen V., Porpiglia, Andrea, Bleicher, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504964/
https://www.ncbi.nlm.nih.gov/pubmed/34635974
http://dx.doi.org/10.1245/s10434-021-10883-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504964/
https://www.ncbi.nlm.nih.gov/pubmed/34635974
http://dx.doi.org/10.1245/s10434-021-10883-5

Ejemplares similares